NDC properties for NDC 9 0065-0652
NDC item 00065065205
NDC 9 | 0065-0652 |
---|---|
NDC 10 | 0065-0652-05 |
NDC Item | 00065065205 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (0065-0652-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 525776 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2021-06-30 |
Marketing effective time low | 2010-09-07 |
Marketing status | COMPLETED |
NDA | NDA050818 |
NDC item 71776003501
NDC 9 | 71776-035 |
---|---|
NDC 10 | 71776-035-01 |
NDC Item | 71776003501 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (71776-035-01) / 1 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 854678 |
Labeler | Eyevance Pharmaceuticals, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2021-05-19 |
Marketing status | ACTIVE |
NDA | NDA050818 |
NDC item 71776003505
NDC 9 | 71776-035 |
---|---|
NDC 10 | 71776-035-05 |
NDC Item | 71776003505 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (71776-035-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 854678 |
Labeler | Eyevance Pharmaceuticals, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2021-05-19 |
Marketing status | ACTIVE |
NDA | NDA050818 |
NDC item 82667001100
NDC 9 | 82667-011 |
---|---|
NDC 10 | 82667-011-00 |
NDC Item | 82667001100 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (82667-011-00) / 1 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 868053 |
Labeler | Harrow Eye, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2025-03-31 |
Marketing status | active |
NDA | NDA050818 |
NDC item 82667001105
NDC 9 | 82667-011 |
---|---|
NDC 10 | 82667-011-05 |
NDC Item | 82667001105 |
packaging | 1 BOTTLE, DROPPER in 1 CARTON (82667-011-05) / 5 mL in 1 BOTTLE, DROPPER |
FDA SPL set id | 868053 |
Labeler | Harrow Eye, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2025-03-31 |
Marketing status | active |
NDA | NDA050818 |